ROYAL BANK OF CANADA - ALLOVIR INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$18,000
+20.0%
8,547
+95.4%
0.00%
Q2 2023$15,000
+87.5%
4,374
+107.7%
0.00%
Q1 2023$8,000
-55.6%
2,106
-40.8%
0.00%
Q4 2022$18,000
+500.0%
3,555
+833.1%
0.00%
Q3 2022$3,000
+50.0%
381
-19.8%
0.00%
Q2 2022$2,000
-85.7%
475
-77.5%
0.00%
Q1 2022$14,000
-83.5%
2,112
-67.8%
0.00%
Q4 2021$85,000
+16.4%
6,559
+126.2%
0.00%
Q3 2021$73,000
+52.1%
2,900
+17.3%
0.00%
Q2 2021$48,000
-14.3%
2,472
+4.7%
0.00%
Q1 2021$56,000
+124.0%
2,362
+260.6%
0.00%
Q4 2020$25,000
-94.3%
655
-95.9%
0.00%
Q3 2020$436,00015,8500.00%
Other shareholders
ALLOVIR INC shareholders Q4 2023
NameSharesValueWeighting ↓
Artal Group S.A. 2,323,371$89,310,0001.92%
Redmile Group, LLC 2,325,595$89,396,0001.08%
Woodline Partners LP 1,039,880$39,973,0001.06%
EcoR1 Capital, LLC 447,012$17,183,0000.92%
Samsara BioCapital, LLC 82,336$3,165,0000.32%
CNA FINANCIAL CORP 11,285$434,0000.14%
AMERICAN INTERNATIONAL GROUP, INC. 910,419$34,997,0000.13%
Virtus ETF Advisers LLC 7,339$282,0000.12%
Maven Securities LTD 19,901$799,0000.08%
TCW GROUP INC 216,135$8,308,0000.07%
View complete list of ALLOVIR INC shareholders